{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:48:37Z","timestamp":1785235717374,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81425012, 91529305, 81601419, 81372211 and 81672425"],"award-info":[{"award-number":["81425012, 91529305, 81601419, 81372211 and 81672425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2015HZ005, ZR2016HB16, 2016GSF201064, 2016ZDJS07A17 and 2017GSF18185"],"award-info":[{"award-number":["ZR2015HZ005, ZR2016HB16, 2016GSF201064, 2016ZDJS07A17 and 2017GSF18185"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007641","name":"Foundation for the Development of Science and Technology Museums in China","doi-asserted-by":"publisher","award":["2016YFE0127000"],"award-info":[{"award-number":["2016YFE0127000"]}],"id":[{"id":"10.13039\/501100007641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01124","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T04:23:17Z","timestamp":1527654197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication"],"prefix":"10.3389","volume":"9","author":[{"given":"Di","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2016.07.009","article-title":"Hepatocarcinogenesis associated with hepatitis B, delta and C viruses","volume":"20","author":"Shirvani-Dastgerdi","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.vaccine.2017.03.049","article-title":"Chronic hepatitis B: immunological profile and current therapeutic vaccines in clinical trials","volume":"35","author":"Lobaina","year":"2017","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: a double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/cmi.2014.91","article-title":"NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma","volume":"12","author":"Sun","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1097-2765(00)80071-4","article-title":"Crystal structure of the N-terminal domain of sialoadhesin in complex with 3\u2032 sialyllactose at 1.85 A resolution","volume":"1","author":"May","year":"1998","journal-title":"Mol Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwj008","article-title":"Siglecs \u2013 the major subfamily of I-type lectins","volume":"16","author":"Varki","year":"2006","journal-title":"Glycobiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1093\/oxfordjournals.glycob.a018832","article-title":"Siglecs: a family of sialic-acid binding lectins","volume":"8","author":"Crocker","year":"1998","journal-title":"Glycobiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/labinvest.3700656","article-title":"Diversity in cell surface sialic acid presentations: implications for biology and disease","volume":"87","author":"Varki","year":"2007","journal-title":"Lab Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ni.f.203","article-title":"Protein-glycan interactions in the control of innate and adaptive immune responses","volume":"9","author":"van Kooyk","year":"2008","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.4049\/jimmunol.173.11.6841","article-title":"The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells","volume":"173","author":"Avril","year":"2004","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22127","DOI":"10.1074\/jbc.M002775200","article-title":"Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways","volume":"275","author":"Angata","year":"2000","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22121","DOI":"10.1074\/jbc.M002788200","article-title":"Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1182\/blood-2016-11-751636","article-title":"Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation","volume":"129","author":"Lizcano","year":"2017","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"20370","DOI":"10.1074\/jbc.M114.574624","article-title":"Siglec-E promotes beta2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung","volume":"289","author":"McMillan","year":"2014","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1182\/blood-2008-11-187302","article-title":"Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response","volume":"113","author":"Carlin","year":"2009","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1182\/blood-2004-10-4112","article-title":"Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment","volume":"106","author":"von Gunten","year":"2005","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ni.3552","article-title":"The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9","volume":"17","author":"Beatson","year":"2016","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1476-4598-9-118","article-title":"Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes","volume":"9","author":"Belisle","year":"2010","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1172\/JCI65899","article-title":"Interactions between siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance","volume":"124","author":"Jandus","year":"2014","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jmv.23727","article-title":"Important roles played by TGF-beta in hepatitis B infection","volume":"86","author":"Karimi-Googheri","year":"2014","journal-title":"J Med Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1159\/000430386","article-title":"Involvement of interleukin 6 in hepatitis B viral infection","volume":"37","author":"Xia","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"72961","DOI":"10.18632\/oncotarget.12150","article-title":"PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma","volume":"7","author":"Beldi-Ferchiou","year":"2016","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/eji.200323693","article-title":"Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via Siglec-7-dependent and -independent mechanisms","volume":"33","author":"Nicoll","year":"2003","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/glycob\/cwq116","article-title":"Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells","volume":"20","author":"Kawasaki","year":"2010","journal-title":"Glycobiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/gutjnl-2015-310327","article-title":"Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection","volume":"65","author":"Varchetta","year":"2016","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10719-010-9316-z","article-title":"Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients","volume":"28","author":"Mondal","year":"2011","journal-title":"Glycoconj J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T04:23:26Z","timestamp":1527654206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2018.01124"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01124","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"article-number":"1124"}}